Effect of controlled ovarian hyperstimulation treatment on cardiac function

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 55, Issue 11-12, 2010, Pages 503-508

  Uckuyu, Ayla ^a   Ciftci, Ceylan F ^a   Ozcimen, Emel E ^a   Ciftci, Ozgur ^a   Toprak, Erzat ^a   Turhan, Erdem ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cardiac function; Controlled ovarian hyperstimulation; Doppler imaging; Estrogen

Indexed keywords

CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ARTICLE; CONTROLLED OVARY HYPERSTIMULATION; CONTROLLED STUDY; DECELERATION; FEMALE; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE FILLING; HEART MUSCLE COMPLIANCE; HEART VOLUME; HUMAN; LATERAL ISOVOLUMIC RELAXATION TIME; LEFT VENTRICULAR MYOCARDIAL PERFORMANCE INDEX; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; RELAXATION TIME; REPEAT PROCEDURE; RIGHT VENTRICULAR MYOCARDIAL PERFORMANCE INDEX; THERAPY EFFECT; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE;

ADULT; BLOOD PRESSURE; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; GONADOTROPIN-RELEASING HORMONE; HEART RATE; HORMONE ANTAGONISTS; HUMANS; OVULATION INDUCTION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT; YOUNG ADULT;

EID: 79951569325     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340: 1801-1811
2. Simoncini T, Genazzani AR, Liao JK: Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 2002;105:1368-1373
3. Morey AK, Pedram A, Razandi M, et al: Estrogen and progesterone inhibit vascular smooth muscle proliferation. Endocrinology 1997;138:3330-3339
4. Nascimento CA, Kauser K, Rubanyi GM: Effect of 17betaestradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. Am J Physiol 1999;276:H1788-H1794
5. Eickels M, Grohe C, Cleutjens JP, et al: 17beta-Estradiol attenuates the development of pressure-overload hypertrophy. Circulation 2001;104:1419-1423
6. Sudoh N, Toba K, Akishita M, et al: Estrogen prevents oxidative stress-induced endothelial cell apoptosis in rats. Circulation 2001;103:724-729
7. Lind L, Andren B, Arnlov J: The Doppler-derived myocardial performance index is determined by both left ventricular systolic and diastolic function as well as by afterload and left ventricular mass. Echocardiography 2005;22:211-216
8. Tei C: New non-invasive index for combined systolic and diastolic ventricular function. J Cardiol 1995;26:135-136
9. European Society of Human Reproduction and Embryology: World report on assisted reproductive technology. Prague, Czech Republic, 2006
10. Kerin JF, Warnes GM, Quinn P, et al: Endocrinology of ovarian stimulation for in vitro fertilization. Aust NZ J Obstet Gynaecol 1984;24:121-124
11. Korcarz CE, Stein JH: Noninvasive assessment of coronary flow reserve by echocardiography: Technical considerations. J Am Soc Echocardiogr 2004;17:704-707
12. Karakaya O, Barutcu I, Esen AM, et al: Acute smokinginduced alterations in Doppler echocardiographic measurements in chronic smokers. Tex Heart Inst J 2006;33:134-138
13. Aldrighi JM, Alecrin IN, Caldas MA, et al: Effects of estradiol on myocardial global performance index in hypertensive postmenopausal women. Gynecol Endocrinol 2004;19:282-292
14. Rickels MV, Grohe C, Cleutjens JPM, et al: 17â Estradiol attenuates the development of pressure overload hypertrophy. Circulation 2001;104:1419-1423
15. Satoh M, Matter CM, Ogita H, et al: Inhibition of apoptosisregulated signaling kinase-1 and prevention of congestive heart failure by estrogen. Circulation 2007;115: 3197-3204
16. Kim J, Levin ER: Estrogen signaling in the cardiovascular system. Nucl Receptor Signaling 2006;4:e013-e017
17. Pelzer T, Schumann M, Neumann M, et al: 17 Beta-estradiol prevents programmed cell death in cardiac myocytes. Biochem Biophys Res Commun 2000;268:192-200
18. Zengin K, Tokac M, Duzenli MA, et al: Influence of menstrual cycle on cardiac performance. Maturitas 2007;58:70-74
19. Patten RD, Pourati I, Aronovitz MJ, et al: 17â-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circulation Res 2004;95:692-699